A detailed history of Center For Financial Planning, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Center For Financial Planning, Inc. holds 494 shares of RGEN stock, worth $74,149. This represents 0.01% of its overall portfolio holdings.

Number of Shares
494
Previous 368 34.24%
Holding current value
$74,149
Previous $46,000 32.61%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 04, 2025

BUY
$108.89 - $145.23 $13,720 - $18,298
126 Added 34.24%
494 $61,000
Q1 2025

Apr 22, 2025

BUY
$127.24 - $174.24 $24,557 - $33,628
193 Added 110.29%
368 $46,000
Q4 2020

Feb 09, 2021

BUY
$148.08 - $206.57 $25,914 - $36,149
175 New
175 $34,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.33B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Center For Financial Planning, Inc. Portfolio

Follow Center For Financial Planning, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center For Financial Planning, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Center For Financial Planning, Inc. with notifications on news.